cycloastragenol has been researched along with Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, XM; Li, HH; Li, J; Liu, Z; Pan, LH; Peng, T; Ren, YS; Tan, YJ; Yao, JC; Yue, J; Zhang, GM; Zhao, LL | 1 |
1 other study(ies) available for cycloastragenol and Myocardial Infarction
| Article | Year |
|---|---|
Application quantitative proteomics approach to identify differentially expressed proteins associated with cardiac protection mediated by cycloastragenol in acute myocardial infarction rats.
Topics: Animals; Apoptosis; Humans; I-kappa B Kinase; Monomeric GTP-Binding Proteins; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Proteomics; Rats; Sapogenins | 2020 |